Press Release CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program CROSSJECT enhanced its collaboration with Eton Pharmaceuticals, Inc. ( ...

Currently, contraceptive implants last for years but the device needs to be fitted inside a woman by a trained professional ...

Novel drug delivery approach that utilizes long-acting injectable microcrystals may enable new options for long-term delivery ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...

First-in-human studies anticipated to begin in 2026Engaged a top tier U.S. based contract manufacturer to ensure the highest standards of ...

MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a ...

Engineers devised a way to deliver drugs such as contraceptives by injecting them as suspended crystals. Once under the skin, the crystals assemble into a drug depot that can last for months or years, ...

BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for ...

The team from Massachusetts Institute of Technology (MIT) have suggested that the technology could be useful for applications ...

MIT engineers have developed a new drug delivery method that could change long-term treatments with fewer injections and less ...